Clinical Trials List
2023-12-01 - 2026-07-11
Phase I
Recruiting4
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Jih-Hsiang Lee Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- 楊景堯 Division of Hematology & Oncology
- 蔡子修 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Hematology & Oncology
- YEN-TING LIN Division of Hematology & Oncology
- 許嘉林 Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- 吳宗哲 Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- 廖唯昱 Division of Hematology & Oncology
- 吳尚俊 Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蔡英楠 Division of Hematology & Oncology
- 蔡郁棻 Division of Hematology & Oncology
- 陳志城 Division of Hematology & Oncology
- Meng-Jer Hsieh Division of Hematology & Oncology
- 曾政豪 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 余紹銘 Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
- Chan-Keng Yang Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- Wen-Chi Chou Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- Ming-Mo Hou Division of Hematology & Oncology
- Tsai-Sheng Yang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chen-Yuan Lin Division of Hematology & Oncology
- Li-Yuan Bai Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
28 participants
-
Global
260 participants